The DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index, and 1 are not checked yet; 15 of the 51 sources its claims cite were checked for support.
MicroRNA 21 Promotes Glioma Invasion by Targeting Matrix Metalloproteinase Regulators
Open accessAbstract
Substantial data indicate that microRNA 21 (miR-21) is significantly elevated in glioblastoma (GBM) and in many other tumors of various origins. This microRNA has been implicated in various aspects of carcinogenesis, including cellular proliferation, apoptosis, and migration. We demonstrate that miR-21 regulates multiple genes associated with glioma cell apoptosis, migration, and invasiveness, including the RECK and TIMP3 genes, which are suppressors of malignancy and inhibitors of matrix metalloproteinases (MMPs). Specific inhibition of miR-21 with antisense oligonucleotides leads to elevated levels of RECK and TIMP3 and therefore reduces MMP activities in vitro and in a human model of gliomas in nude mice. Moreover, downregulation of miR-21 in glioma cells leads to decreases of their migratory and invasion abilities. Our data suggest that miR-21 contributes to glioma malignancy by downregulation of MMP inhibitors, which leads to activation of MMPs, thus promoting invasiveness of cancer cells. Our results also indicate that inhibition of a single oncomir, like miR-21, with specific antisense molecules can provide a novel therapeutic approach for "physiological" modulation of multiple proteins whose expression is deregulated in cancer.
Verified 2026-10-19 · 1 reference not checked yet
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
miR-21 is elevated in high-grade gliomas and promotes glioma invasion by directly targeting the MMP inhibitor RECK and indirectly regulating TIMP3, leading to increased MMP activity. Inhibiting miR-21 raises RECK/TIMP3, reduces MMP activity in vitro and in vivo, and decreases glioma cell motility and invasion, partly rescued by RECK knockdown.
Key findings
- miR-21 levels remain low in grade II gliomas and most grade III tumors but are significantly higher in GBMs; RECK mRNA is significantly lower in GBMs than normal brain and grade II/III gliomas, and TIMP3 mRNA tends to be lower in GBMs.
- Anti-miR-21 treatment changed expression of ∼570 genes (P < 0.05); upregulated transcripts were enriched for miR-21 seed hexamers (expectations 1.45e−09, 1.37e−14, and 1.82e−12), and at least 65 mRNAs were upregulated by anti-miR-21 and downregulated by miR-21 overexpression.
- miR-21 inhibition increased RECK mRNA ∼2-fold and TIMP3 mRNA about 1.6-fold; RECK was validated as a direct miR-21 target by luciferase reporter, whereas TIMP3 was not consistently directly responsive and is likely downstream.
- miR-21 inhibition reduced MMP-2 activity in A172 and U87 cells and lowered MMP activity in U87 subcutaneous tumors in nude mice; it also reduced scratch motility and Matrigel invasion, with reduced motility partly rescued by RECK siRNA and reduced invasion not observed when anti-miR-21 was cotransfected with RECK siRNA.
Methods
- Human glioma cell lines A172, U87, and LN229 (high miR-21), plus HeLa, MCF7, and U2OS cells, and human nonneoplastic brain and tumor samples; cells were transfected with 2′-O-MOE anti-miR-21, mismatch/control oligonucleotides, synthetic miR-21 duplex, or RECK siRNA.
- mRNA profiling used Agilent 44K arrays at 6 and 24 h posttreatment, with qRT-PCR, Western blot, luciferase 3′ UTR reporter assays with mutated miR-21 binding sites, gelatin zymography, scratch migration, and Matrigel invasion assays.
- In vivo, U87 cells transfected with anti-miR-21 or control were implanted subcutaneously in nude mice; MMP activity was imaged with MMPSense 680 at 3 days after implantation and 24 h later, with caliper tumor measurements.
Limitations
- Stated by the authors: the 2′-O-MOE anti-miR-21 did not significantly or consistently change glioma cell viability or reduce subcutaneous U87 tumor growth; subcutaneous U87 tumors are noninfiltrative, noninvasive, and poorly vascularized, so they are not an accurate model for studying invasiveness and tumor growth; nucleic acid chemistry can profoundly alter cellular responses to miRNA inhibition; therapeutic potential requires future research.
- Stated/evident from the text: the TIMP3 3′ UTR reporter did not consistently respond to miR-21 changes, so TIMP3 is likely a downstream effector rather than a direct target; RECK protein bands were not detectable by Western blot in U87 cells despite ∼2-fold RECK mRNA upregulation.
- Evident from the text: in vivo imaging was performed within the first week, when anti-miR-21 did not affect subcutaneous U87 tumor growth; comparison with a prior intracranial LNA-DNA anti-miR-21 study is limited because tumor locations differed.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 of 51 cited sources checked · 11 supported · 0 flagged · accuracy not yet measured
Every source the paper cites for this claim was checked and supports it.
In the paper
“Among the molecules tested, the 2′-O-MOE ASO was the most potent in repressing miR-21 activity (Fig. 2A), in agreement with previous data (10), whereas the uniform 2′-O-methyl ASO was the least potent, and mixed locked nucleic acid (LNA)-DNA oligonucleotides were variable (data not shown).”
What the sources say
- Supportedcites [10] source
The Discussion explicitly identifies the uniformly modified 2′-O-MOE-PO oligonucleotide as the best anti-miRNA ASO tested. This supports the attributed comparison for miR-21 activity, although the passage specifies the oligonucleotide’s backbone as PO. (LLM, conf=0.94)
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Concurring with previously published reports (12, 46), our data indicate that these MMP inhibitors regulate MMP activity posttranslationally.”
What the sources say
- Supportedcites [12] source
The paper describes TIMPs as inhibitors of metalloproteinase activity and shows that TIMP-3 controls the cell-surface activation of pro-MMP-2 (Abstract and Discussion; page numbers unavailable). Its gene-expression analysis found comparable MMP-2 levels in wild-type and TIMP-3-deficient cells despite altered processing, supporting regulation after translation. (LLM, conf=0.91)
- Not checked — no full text of the sourcecites [46] source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Rests on an assumption: MMPs are a group of peptidases involved in degradation of the ECM.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“However, we have not detected any correlation between miR-21-modulated expression in several glioma cell lines and protein level of phosphatase and tensin homolog (data not shown), the reported miR-21 target in hepatocellular carcinomas (44).”
What the sources say
- Supportedcites [44] source
The citation supports the identification of PTEN as a reported miR-21 target in hepatocellular carcinoma: the Results state that PTEN was shown to be a direct target of miR-21 in HCC cells. The preceding statement about no correlation in glioma cell lines is the citing authors’ own unpublished observation, not a finding attributed to this source. (LLM, conf=0.94)
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Our data suggest that this can be at least partly due to miR-21 regulation, in addition to the reported chromosome 12q22-23 loss of heterozygosity and hypermethylation (56).”
What the sources say
- Partly supportedcites [56] Watanabe T., 2003, Brain Pathol. sourceExperimental — accuracy not yet measured
The Abstract (page unavailable) reports chromosome 12q22–23 loss of heterozygosity in glioblastomas and its association with low Apaf-1 expression. It mentions hypermethylation only as a possible mechanism in some malignancies; the reported study did not measure it in glioblastomas. The miR-21 proposal is presented as the citing authors’ own conclusion, not as a finding attributed to this source. (LLM, conf=0.83)
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In gliomas, APAF1 is often inactivated or downregulated (56).”
What the sources say
- Partly supportedcites [56] Watanabe T., 2003, Brain Pathol. sourceExperimental — accuracy not yet measured
The Abstract reports low APAF1 mRNA and protein expression in many glioblastomas with chromosome 12q22–23 loss of heterozygosity. The study examined glioblastoma, however, so it does not establish that APAF1 is often inactivated or downregulated across gliomas generally. (LLM, conf=0.85)
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The numbers of invasive A172 and U87 cells in cultures with inhibited miR-21 were significantly reduced relative to those in cultures transfected with the control oligonucleotide (Fig. 7A and B).”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesThe paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Specific inhibition of miR-21 with antisense oligonucleotides leads to elevated levels of RECK and TIMP3 and therefore reduces MMP activities in vitro and in a human model of gliomas in nude mice.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Moreover, downregulation of miR-21 in glioma cells leads to decreases of their migratory and invasion abilities.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“RECK mRNA expression was significantly lower in GBMs than in normal brain tissue and, especially, in grade II and III gliomas.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“When miR-21 was suppressed, the amount of gelatin digested that reflects the levels of MMP-2 proteolytic activity was significantly reduced relative to the amount for the cells transfected with the control oligonucleotide (Fig. 5A).”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes
- It may state two separate claims as one. 28
- Probably not a substantial claim. 21
- The quote only partly states this claim. 2
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Accumulated data suggested that MMP levels and activities are significantly elevated in human gliomas, which contributes to glioma cell invasion of the surrounding normal tissues, metastasis, and angiogenesis through cell surface ECM degradation (21, 45).”
What the sources say
- Not checked — no full text of the sourcecites [21] Hu B., 2003, Proc. Natl. Acad. Sci. USA source
- Partly supportedcites [45] sourceExperimental — accuracy not yet measured
The Abstract and §4.1 link elevated MMP levels in human gliomas to invasiveness, and describe ECM degradation and cell-surface activation. But the Abstract discusses metastasis in cancer generally, not specifically gliomas; §4.2 links MMP-9 to angiogenesis only tentatively and says its activity in invasive glioma tissue is unproven. The copy therefore does not establish significantly elevated MMP activities across human gliomas or the claimed glioma metastasis and angiogenesis mechanism. Page numbers were not supplied. (LLM, conf=0.88)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Rests on an assumption: MMPs are a group of peptidases involved in degradation of the ECM.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“TIMP3 is a tissue inhibitor of MMPs that inhibits angiogenesis and tumor cell infiltration and also induces apoptosis (2, 48).”
What the sources say
- Partly supportedcites [2] sourceExperimental — accuracy not yet measured
The paper’s Summary (p. 1347) identifies TIMP-3 as a tissue inhibitor of metalloproteinases, and its discussion reports inhibited invasion of HeLa and HT1080 cancer cells and apoptotic death in three cancer cell lines. The copy does not report that TIMP-3 inhibits angiogenesis; searches for angiogenesis and blood-vessel formation found no supporting passage. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [48] source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim. It may state two separate claims as one.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“This microRNA has been implicated in various aspects of carcinogenesis, including cellular proliferation, apoptosis, and migration.”
- Also stated in: § Abstract · plain
“miR-21 has been identified in controlling apoptosis, cell proliferation, and migration of cell lines in breast, colorectal, and other cancers (1, 44, 51, 59).”
What the sources say
- Not checked — no full text of the sourcecites [1] source
- Supportedcites [44] source
The Results report that changing miR-21 expression affects proliferation and migration in HCC cells. The Discussion also reports anti-apoptotic properties of miR-21 in glioblastoma and cholangiocarcinoma, supporting the broader statement that it has been implicated in all three processes. (LLM, conf=0.92)
- Not checked — no full text of the sourcecites [51] source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
- Also stated in: § Abstract · plain
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Our analysis also confirmed tropomyosin 1 (TPM1) regulation by miR-21, previously reported to occur in MCF7 cells (59, 60).”
What the sources say
- Supportedcites [59] source
The Abstract reports that experiments using tumors derived from MCF-7 cells identified TPM1 as a miR-21 target and confirmed that miR-21 down-regulates its expression. The Results section also reports increased endogenous TPM1 in anti-miR-21-treated, MCF-7-derived tumors. The paper therefore supports the cited prior report, although its tumor measurements were made in MCF-7-derived tumors rather than isolated cells. (LLM, conf=0.90)
- Not checked — no full text of the sourcecites [60] source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Another factor that can induce miR-21 expression is hypoxia, a general feature of all solid tumors (30).”
What the sources say
- Supportedcites [30] source
The Results report miR-21 among the hypoxia-regulated microRNAs and say its microarray result was checked by quantitative RT-PCR. The introductory passage describes hypoxia as an essential feature of the neoplastic microenvironment. (LLM, conf=0.90)
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The miR-21 gene contains two conserved STAT3 binding sites within its enhancer region and is induced by interleukin 6 (IL-6) in a STAT3-dependent way.”
What the sources say
- Supportedcites [39] source
The Results and discussion section identifies two conserved Stat3 binding sites in the miR-21 upstream regulatory region. It also reports that IL-6 increased miR-21 expression and that Stat3 knockdown inhibited this induction. (LLM, conf=0.94)
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“MMPs can degrade ECM components and therefore play important roles in mediating GBM tumor cell motility and invasion (45).”
What the sources say
- Supportedcites [45] source
The Introduction says MMPs can degrade nearly all ECM macromolecules in the brain and are believed to play a major role in tumor invasion. The Abstract links MMP-mediated ECM degradation to glioblastoma invasion, while Section 4 describes how ECM degradation may permit glioma-cell migration. (LLM, conf=0.92)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“APAF1 (apoptotic protease activating factor 1) is the molecular core of apoptosome. It is typically required for activation of the caspases that initiate apoptosis (3, 26).”
What the sources say
- Supportedcites [3] source
The Introduction describes Apaf-1 oligomerization as forming the apoptosome, while the Results and discussion state that Apaf-1 normally recruits and activates caspases-9 and -3. The Concluding remarks add that caspase-9 activity depends on interaction with oligomerized Apaf-1. Page numbers are not provided in our copy. (LLM, conf=0.90)
- Supportedcites [26] Johnson C. E., 2007, Proc. Natl. Acad. Sci. USA source
The paper’s introductory discussion (page not specified in our copy) says cytochrome c binds Apaf-1, leading to recruitment of procaspase-9 and formation of the apoptosome; the apoptosome then activates caspase-9. In the section on Apaf-1 expression levels (page not specified), adding Apaf-1 enabled cytochrome c to activate caspases in neural extracts, supporting its required role in the pathway described. (LLM, conf=0.91)
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Elevated miR-21 expression has been causally linked to proliferation, apoptosis, and migration of several cancer cell lines (1, 5, 44, 60).”
What the sources say
- Not checked — no full text of the sourcecites [1] source
- Not checked — no full text of the sourcecites [5] source
- Supportedcites [44] source
The Results report that experimentally increasing or inhibiting miR-21 changed proliferation and migration in HCC cell lines. The Discussion reports anti-apoptotic properties of miR-21 in glioblastoma and cholangiocarcinoma, supporting the apoptosis part as a finding the paper reports from other studies. (LLM, conf=0.87)
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“miR-21 levels remain low in grade II gliomas and in most grade III tumors and are significantly higher in GBMs (Fig. 1).”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“This expression pattern is different from those of the other cancer-associated miRNAs, for example, miR-10b, which is often elevated in grade III and even grade II gliomas (Fig. 1) and dysregulated in some other cancers (41).”
What the sources say
- Not checked — no full text of the sourcecites [41] source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“RECK mRNA level increased consistently ∼2-fold and TIMP3 mRNA about 1.6-fold in the cells transfected with anti-miR-21.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These experiments demonstrated that inhibition of miR-21 reduced the motility of glioma cells (Fig. 6B and C).”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesThe quote only partly states this claim.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“We note that, though 2′-O-MOE miR-21 ASO induced many proapoptotic and cell cycle arrest genes (Fig. 2C; also see Table S1 in the supplemental material), it did not significantly and consistently change the viability of glioma cell lines, which was reported for other, less potent miR-21 inhibitors (5, 8).”
What the sources say
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“STAT3, the other gene that may play a tumor suppressor function in GBM (11), is also negatively regulated by miR-21 according to the microarray data (see Table S1 in the supplemental material) and is a predicted miR-21 target (29, 34).”
What the sources say
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“As identified in our study, TIMP3 or both TIMP3 and RECK are also induced by anti-miR-21 in MCF7 (breast carcinoma) and U2OS (osteosarcoma) cells (Fig. 4D).”
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In glioma progression from less invasive grade II gliomas to very invasive GBMs, RECK and TIMP3 levels drop (Fig. 4B), whereas miR-21 expression increases (Fig. 1).”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Here, we show that a 2′-O-MOE ASO not only is potent but also upregulates miR-21 seed-containing mRNAs (Fig. 2 and 3).”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Substantial data indicate that microRNA 21 (miR-21) is significantly elevated in glioblastoma (GBM) and in many other tumors of various origins.”
- Also stated in: § Abstract · boosted
“Using high-throughput profiling of miRNA expression, we have previously identified a specific miRNA, miRNA 21 (miR-21), as most strongly elevated in nearly all analyzed human GBM specimens (5).”
- Also stated in: § Abstract · boosted
“Other groups demonstrated overexpression of this miRNA in a wide range of other cancers, including breast, lung, colon, prostate, pancreas, ovarian, and stomach cancers, as well as in chronic lymphocytic leukemia (33, 54).”
What the sources say
Strength:boosted· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
- Also stated in: § Abstract · boosted
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“mRNAs carrying RECK and TIMP3 are predicted conserved miR-21 targets with one and two putative binding sites, respectively (Fig. 4A).”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The sequences of the control and mismatch oligonucleotides have been analyzed using BLAST searches to exclude potential hits in the human transcriptome.”
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“RECK is a membrane-anchored MMP inhibitor whose reduced expression or inactivation seems to be critical for the invasiveness and metastasis of various cancers, including glioma cancer (7, 46).”
What the sources say
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The high level of miR-21 expression in GBMs compared to that in anaplastic astrocytomas suggests the involvement of miR-21 in one of these key processes.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesThe quote only partly states this claim.
In the paper
“Its expression level is also an important prognostic factor for multiple cancer types (6).”
What the sources say
- Not checked — no full text of the sourcecites [6] source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“It has been demonstrated to inhibit MMP activity and tumor growth in malignant gliomas in vivo (31, 32).”
What the sources say
Strength:boosted· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Since modified oligonucleotides can induce a wide range of nonspecific, off-target-mediated effects, several ASO molecules of different chemistries have been used for miR-21 inhibition.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Our data suggest that miR-21 contributes to glioma malignancy by downregulation of MMP inhibitors, which leads to activation of MMPs, thus promoting invasiveness of cancer cells.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Rests on an assumption: MMPs are a group of peptidases involved in degradation of the ECM.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Such overrepresentation of the hexamers suggests an abundance of direct miR-21 targets among the genes upregulated by 2′-O-MOE anti-miR-21 and indicates that the effects of this molecule on glioma cells are indeed mediated through the miR-21 pathway.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“These experiments have been performed with the miR-21 inhibitor and with a mismatched control oligonucleotide to ensure that any observed effects are driven by miR-21.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
In the paper
“Importantly, it inhibits tumor necrosis factor alpha-converting enzyme and induces apoptosis through the stabilization of tumor necrosis factor alpha receptors on the cell surface (42).”
What the sources say
- Not checked — no full text of the sourcecites [42] source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Moreover, it leads to reduction of glioma cell motility and invasion, which is mediated by elevated RECK expression and was partly rescued by RECK siRNA (Fig. 6 and 7).”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This implies that miR-21 regulates RECK and TIMP3 expression and thus MMP activities and glioma tumor invasiveness.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In this study, we have demonstrated in vitro and in vivo, using U87 glioma xenografts in nude mice, that miR-21 regulates MMPs and glioma cell invasiveness by directly controlling the MMP inhibitor RECK.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These combined results indicate that miR-21 regulates overlapping though not identical sets of genes in different cells and therefore shares common signaling pathways in different cancers.”
Strength:hedged· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The APAF1 3′ UTR contains a strong miR-21 binding site (9-mer binding at miR-21 5′ end), and therefore, it is likely one of the direct miR-21 targets.”
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Its expression is highly upregulated in a variety of solid tumors, including GBM, breast, lung, colon, prostate, pancreas, and stomach cancers (5, 54).”
What the sources say
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Our mRNA expression analysis suggests that miR-21 regulates the expression of multiple mRNA targets and thereby induces several cellular programs in glioma cells, including those associated with the tumor invasiveness and microvascular proliferation typical for the GBM as well as those involved in cell cycle regulation and apoptosis.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Its ectopic expression in glioma cells induces upregulation of genes associated with angiogenesis, growth factors, cytokines, death receptors, and substrates of the various MMPs (31).”
What the sources say
- Not checked — no full text of the sourcecites [31] Lam P., 2005, Mol. Ther. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“RECK, a membrane-anchored regulator, and TIMP3, the ECM-bound protease regulator, are key inhibitors of several MMPs, and their expression is prognostic in a number of common cancers (28, 53).”
What the sources say
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“TIMP3 has been demonstrated to activate caspases and therefore induce apoptosis of human glioma cells in vitro and the growth inhibition of human glioma tumors in a mouse model (31, 32).”
What the sources say
Strength:boosted· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Though mRNA expression analysis does not allow identification of targets whose translation is regulated without modulation of mRNA levels”
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Such a bidirectional approach to manipulating miR-21 levels enabled narrowing of the lists of regulated genes and identification of those whose expression correlated negatively with miR-21 levels”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“In these experiments, we used tumorigenic U87 cells, a common model of human gliomas (23).”
What the sources say
- Not checked — no full text of the sourcecites [23] source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
The paper relies on this without support.
MMPs are a group of peptidases involved in degradation of the ECM.
“MMPs are a group of peptidases involved in degradation of the ECM.”
The paper relies on this without support.
Subcutaneous U87 tumors are noninfiltrative, noninvasive, and poorly vascularized.
“We should also note that subcutaneous U87 tumors are noninfiltrative, noninvasive, and poorly vascularized.”
The paper relies on this without support.
Knowledge of the molecular mechanisms mediating miR-21 function in cancer generally and in gliomas specifically is limited.
“However, our knowledge of the molecular mechanisms mediating miR-21 function in cancer generally and gliomas specifically is limited.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“miR-21 is a well-known miRNA, found to be overexpressed in almost all cancer types, where its upregulation promotes cell proliferation, invasion, and metastatic behavior.”
From Potential Therapeutic Effects of Exosomes Packed With a miR-21-Sponge Construct in a Rat Model of Glioblastoma (2019) · cites this paper as [17]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Previous studies have proven that PDCD4, HNRNPK and RECK are TSGs among the direct targets of miR-21-5p (13,(27)(28)(29).”
From Functional interaction between miR-505-3p and miR-21 contributes to GBM suppression (2026) · cites this paper as [28]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“miR-21 targets several genes such as PDCD4, TIMP3, and RECK, which are key regulators of apoptotic and metastatic pathways (17–23).”
From Potential Therapeutic Effects of Exosomes Packed With a miR-21-Sponge Construct in a Rat Model of Glioblastoma (2019) · cites this paper as [17]
The cited source says what the claim attributes to it.
In the citing paper
“Our data on the effects of miR-21 enriched exosomes is in agreement with the previous reports demonstrating that overexpressed miR-21 in cell lines can increase the proliferation rate and malignant behavior of the cells (17–23).”
From Potential Therapeutic Effects of Exosomes Packed With a miR-21-Sponge Construct in a Rat Model of Glioblastoma (2019) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
APAF1 overexpression claim cites a caspase-8 study
MinorIn the APAF1 discussion, the paper attributes apoptosis induced by viral overexpression to APAF1 and cites reference 50. The cited reference instead describes adenovirus-mediated transfer of caspase-8 in combination with a superrepressor of NF-kappaB.
“Its overexpression by viral transduction induces apoptosis in glioma cells and may be beneficial in glioma treatment (50).”
“50.Shinoura, N., N. Yamamoto, Y. Yoshida, A. Asai, T. Kirino, and H. Hamada. 2000. Adenovirus-mediated transfer of caspase-8 in combination with superrepressor of NF-kappaB drastically induced apoptosis in gliomas.”
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005) · Cell · doi:10.1016/j.cell.2004.12.035 · Cited by 11,855
Oncomirs—MicroRNAs with a role in cancer
Esquela-Kerscher, A., & Slack, F. J. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1840 · Cited by 5,884
A microRNA expression signature of human solid tumors defines cancer gene targets
Volinia, S., Calin, G. A., Liu, C.-G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510565103 · Cited by 5,697
Summaries of Affymetrix GeneChip probe level data
Irizarry, R. A. (2003) · Nucleic Acids Research · doi:10.1093/nar/gng015 · Cited by 4,837
Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs
Lim, L. P., Lau, N. C., Garrett-Engele, P., Grimson, A., Schelter, J. M., Castle, J., Bartel, D. P., Linsley, P. S., & Johnson, J. M. (2005) · Nature · doi:10.1038/nature03315 · Cited by 4,755
Self-citationIn vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro
Liang, C.-C., Park, A. Y., & Guan, J.-L. (2007) · Nature Protocols · doi:10.1038/nprot.2007.30 · Cited by 4,696
Combinatorial microRNA target predictions
Krek, A., Grün, D., Poy, M. N., Wolf, R., Rosenberg, L., Epstein, E. J., MacMenamin, P., da Piedade, I., Gunsalus, K. C., Stoffel, M., et al. (2005) · Nature Genetics · doi:10.1038/ng1536 · Cited by 4,603
miRBase: microRNA sequences, targets and gene nomenclature
Griffiths-Jones, S. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj112 · Cited by 3,950
John, B., Enright, A. J., Aravin, A., Tuschl, T., Sander, C., & Marks, D. S. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020363 · Cited by 3,796
Flagged first, then by citations
Research works printed but not linked: 1
- Gao F., 2007, Oncol. Rep., 17, 123
Cited by
Sorted by citations
Items 301–400 of 886
Petrović, N. (2016) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-016-0186-3 · Cited by 66
“There is evidence that RECK is a direct target of miR-21 in both NSCLC [100] and glioblastoma cells [101].”
BackgroundEssential role of miRNAs in orchestrating the biology of the tumor microenvironment
Frediani, J., & Fabbri, M. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0525-3 · Cited by 64
“Working in concert, elevated levels of miR-21 additionally have been shown to cause downregulation of MMP inhibitors RECK and TIMP3 in gliomas and elevated miR-24 down-regulates TIMP2 in breast cancer models, increasing the tumor cells migratory and invasive capabilities [59, 60].”
BackgroundMicroRNA-101 inhibits proliferation, migration and invasion of human glioblastoma by targeting SOX9
Liu, N., Zhang, L., Wang, Z., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13706 · Cited by 64
“Studies have also shown that the knockout of miR-21 could inhibit glioblastoma (GBM) proliferation and induce glioma cells apoptosis [15, 16].”
BackgroundPlasma MicroRNA-21 Concentration May Be a Useful Biomarker in Glioblastoma Patients
Ilhan‐Mutlu, A., Wagner, L., Wöehrer, A., Furtner, J., Widhalm, G., Marosi, C., & Preusser, M. (2012) · Cancer Investigation · doi:10.3109/07357907.2012.708071 · Cited by 68
“MicroRNA-21, one of the most intensively studied microRNAs in cancer biology, was reported to be upregulated in glioblastoma tissue (8, 9).”
BackgroundMicroRNAs in the Regulation of MMPs and Metastasis
Abba, M. L., Patil, N., & Allgayer, H. (2014) · Cancers · doi:10.3390/cancers6020625 · Cited by 64
RNA interference for glioblastoma therapy: Innovation ladder from the bench to clinical trials
Lozada-Delgado, E. L., Grafals‐Ruiz, N., & Vivas‐Mejía, P. E. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.08.027 · Cited by 65
“The use of specific inhibitors have been effective; for instance, the use of a miR-27a inhibitor reduced cell proliferation and induced apoptosis in CRL-1690 GBM cells [45], miR21 inhibition led to a decreased migration and invasion of A172 GBM cells [47], and miR-10b inhibition reduced tumor growth, invasion, and”
MicroRNAs as Molecular Targets for Cancer Therapy: On the Modulation of MicroRNA Expression
Costa, P. M., & de Lima, M. C. P. (2013) · Pharmaceuticals · doi:10.3390/ph6101195 · Cited by 63
“MiR-21 was also shown to target several components of p53, TGF-β and mitochondrial apoptotic networks, in order to decrease apoptotic activation in GBM cells [71], and to enhance tumor cell migration by inhibiting the matrix metalloproteinase (MMP) regulators RECK and TIMP3 [72].”
BackgroundTargeting strategies on miRNA-21 and PDCD4 for glioblastoma
Wang, G., Wang, J. J., Tang, H., & To, S. S. T. (2015) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2015.07.001 · Cited by 67
The metalloproteinase inhibitor Reck is essential for zebrafish DRG development
Prendergast, A. E., Linbo, T. H., Swarts, T., Ungos, J. M., McGraw, H. F., Krispin, S., Weinstein, B. M., & Raible, D. W. (2012) · Development · doi:10.1242/dev.072439 · Cited by 63
“…epigenetic modifications (Chang et al., 2004; Chang et al., 2006; Chang et al., 2007), transcriptional repression (Hsu et al., 2006; Liu et al., 2003; Sasahara et al., 1999), post-translational modifications (Simizu et al., 2005) or endogenous microRNAs (Gabriely et al., 2008; Liu et al., 2010).”
BackgroundmiR-96 promotes tumor proliferation and invasion by targeting RECK in breast cancer
Zhang, J., KONG, X., Li, J., et al. (2013) · Oncology Reports · doi:10.3892/or.2013.2934 · Cited by 63
MicroRNA-320a suppresses in GBM patients and modulates glioma cell functions by targeting IGF-1R
Guo, T.-Z., Feng, Y., Liu, Q., Yang, X., Jiang, T., Chen, Y., & Zhang, Q. (2014) · Tumor Biology · doi:10.1007/s13277-014-2283-4 · Cited by 64
“Recently, some reports suggested that the expressions of miR-21 and miR-181 were abnormal in glioma, which contributed to apoptosis and combat rates of proliferation, invasion, and migration [5, 6].”
Effect of triazophos, fipronil and their mixture on miRNA expression in adult zebrafish
a, X. W., a, S. Z., Ding, X., Zhu, G., & Guo, J. (2010) · Journal of Environmental Science and Health Part B · doi:10.1080/03601234.2010.502435 · Cited by 64
“MiR-21 had been experimentally proven to modulate various tumor suppressors such as caspase-3 and caspase-7 in cultured glioblastoma cells, [ 19 ] RECK and TIMP3 genes in vitro and in a human model of gliomas in nude mice, [ 20 ] phosphatase and tensin homolog tumor suppressor gene in hepatocellular cancer, [ 21 ] and…”
BackgroundNie, Y., Chen, J., Huang, D., Yao, Y., Chen, J., Ding, L., Zeng, J., Su, S., Chao, X., Su, F., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2709 · Cited by 66
Zhou, Y., Li, Y., Ye, J., et al. (2013) · Liver International · doi:10.1111/liv.12190 · Cited by 62
“MiR-21 can down-regulate the MMPs inhibitors, which lead to the activation of MMPs, thus promoting invasiveness of cancer cells (22).”
BackgroundFeghhi, M., Rezaie, J., Akbari, A., Jabbari, N., Jafari, H., Seidi, F., & Szafert, S. (2020) · Materials & Design · doi:10.1016/j.matdes.2020.109227 · Cited by 65
Role of microRNA-mediated MMP regulation in the treatment and diagnosis of malignant tumors
Li, L., & Li, H. (2013) · Cancer Biology & Therapy · doi:10.4161/cbt.25936 · Cited by 64
Strategies to Target Matrix Metalloproteinases as Therapeutic Approach in Cancer
Piperigkou, Z., Manou, D., Καραμάνου, Κ., & Theocharis, A. D. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7595-2_27 · Cited by 62
Spinelli, C., Adnani, L., Choi, D., & Rak, J. W. (2018) · Non-Coding RNA · doi:10.3390/ncrna5010001 · Cited by 66
Development and progression of colorectal neoplasia
Manne, U., Shanmugam, C., Katkoori, V. R., Bumpers, H. L., & Grizzle, W. E. (2011) · Cancer Biomarkers · doi:10.3233/cbm-2011-0160 · Cited by 68
“Up-regulation of miR-21 in CRC cells increases their migratoryand invasivecapacities in a manner similar to that of glioblastomas [234].”
MicroRNA-21 is immunosuppressive and pro-metastatic via separate mechanisms
Chi, L. H., Cross, R. S., Redvers, R. P., Davis, M. J., Hediyeh-zadeh, S., Mathivanan, S., Samuel, M., Lucas, E. C., Mouchemore, K. A., Gregory, P. A., et al. (2022) · Oncogenesis · doi:10.1038/s41389-022-00413-7 · Cited by 68
“Phosphatase and tensin homologue (PTEN) [25, 33] and genes involved in suppression of cell invasion and metastasis, including programmed cell death 4 (PDCD4) [33–35], maspin [27, 35], TIMP3 [36], RECK [36], SMAD7 [37, 38] and tropomyosin (TPM1) [39] were all reported to be down-regulated by miR-21.”
BackgroundJajoo, S., Mukherjea, D., Kaur, T., Sheehan, K. E., Sheth, S., Borse, V., Rybak, L. P., & Ramkumar, V. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4820 · Cited by 62
“In hepatocellular and ovarian cancer cells, miR-21 increased proliferation and metastasis by decreasing phosphatase and tensin homolog deleted on chromosome 10 (PTEN) (27, 31); while in glioma cells, it increased invasion by regulating the matrix metalloproteinase regulators (16).”
The DNA methylome of glioblastoma multiforme
Martínez, R., & Esteller, M. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.12.030 · Cited by 60
“Several miRNAs are weakly expressed in GBM, including miR-124, miR-137, miR-7 and miR-128 (Silber et al., 2008; Godlewski et al., 2008).”
BackgroundmiR-331-3p regulates expression of neuropilin-2 in glioblastoma
Epis, M. R., Giles, K. M., Candy, P. A., Webster, R. J., & Leedman, P. J. (2013) · Journal of Neuro-Oncology · doi:10.1007/s11060-013-1271-7 · Cited by 60
miRNAs in breast cancer tumorigenesis (Review)
ZHANG, Z. J., & Shi, L. (2011) · Oncology Reports · doi:10.3892/or.2011.1611 · Cited by 64
“Previous study reported that miR-21 directly targets TIMP3 in glioma cells and leads to increases of their migratory and invasive abilities (64,65).”
MicroRNA and extracellular vesicles in glioblastoma: small but powerful
Rooj, A. K., Mineo, M., & Godlewski, J. A. (2016) · Brain Tumor Pathology · doi:10.1007/s10014-016-0259-3 · Cited by 60
“Oncogenic miR-21 targets several key factors for both the pro-apoptotic programmed cell death protein 4 [31] and the anti-invasive matrix metalloproteinase regulators RECK (reversion-inducing cysteine-rich protein with kazal motifs) and tissue inhibitor of metalloproteinase 3 [32].”
Dippold, R. P., Vadigepalli, R., Gonye, G. E., & Hoek, J. B. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00019.2012 · Cited by 61
Nabors, B., Fiveash, J. B., Markert, J. M., Kekan, M., Gillespie, G. Y., Huang, Z., Johnson, M. J., Meleth, S., Kuo, H., Gladson, C. L., et al. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.16 · Cited by 59
“Integrin 5- 3 is known to enhance angiogenesis and tumor growth.(19) The genes Table.”
Song, M., Park, Y., & Ryu, J. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.08.016 · Cited by 62
Ho, C., Bar, E. E., Giannini, C., Marchionni, L., Karajannis, M. A., Zagzag, D., Gutmann, D. H., Eberhart, C. G., & Rodriguez, F. J. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos269 · Cited by 59
Mullany, L. E., Herrick, J. S., Wolff, R. K., & Slattery, M. L. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154177 · Cited by 59
“While many factors may contribute to miRNA-mRNA binding, the completeness with which the miRNA binds to the mRNA, and the resulting impact the miRNA has on mRNA expression, is generally thought to be determined by the seed sequence in the miRNA [1, 12, 13].”
BackgroundLuo, G., Luo, W., Sun, X., Lin, J., Wang, M., Zhang, Y., Luo, W., & Zhang, Y. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5971 · Cited by 59
“However, the mechanism involved in miR-21 regulation of glioma cell migration and invasion remains to be elucidated (16,32).”
RetractedDevelopment of microRNA-21 mimic nanocarriers for the treatment of cutaneous wounds
Wang, S. Y., Kim, H., Kwak, G., et al. (2020) · Theranostics · doi:10.7150/thno.39870 · Cited by 59
“migration via inhibition of the expression of PDCD4 and TIMP3, which are known to escalate cell proliferation and migration, respectively [25, 43, 44].”
BackgroundShielding the messenger (RNA): microRNA-based anticancer therapies
Sotillo, E., & Thomas‐Tikhonenko, A. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.04.006 · Cited by 59
“…miR-21 over-expression is common in most cancers, its expression is linked to increased cell growth in cancer cells, and data obtained from knock-down of miR-21 in cell lines supports its role as an oncomiR [reviewed in (Selcuklu et al. 2009; O’Day & Lal, 2010; Gabriely et al. 2008)].”
BackgroundYan, Y., Wang, Q., Xiao-ling, Y. A. N., et al. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.02.005 · Cited by 58
Emerging Roles of microRNA in Modulating Cell‐Death Processes in Malignant Glioma
Palumbo, S., Miracco, C., Pirtoli, L., & Comincini, S. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24446 · Cited by 58
“…effect miR Expression Target Effect Refs. miR10-b Up Cell-cycle inhibitors and pro-apoptotic genes Proliferation promotion and anti-apoptotic effect Gabriely et al. (2011) HOXD10 Invasion and migration phenotype Sun et al. (2011) Down (-miR-10b) Apoptosis, cell growth and invasion arrest Lin et…”
BackgroundA Narrative Review on CD44’s Role in Glioblastoma Invasion, Proliferation, and Tumor Recurrence
Inoue, A., Ohnishi, T., Nishikawa, M., Ohtsuka, Y., Kusakabe, K., Yano, H., Tanaka, J., & Kunieda, T. (2023) · Cancers · doi:10.3390/cancers15194898 · Cited by 59
Beyer, S. J., Fleming, J. L., Meng, W., Singh, R., Haque, S., & Chakravarti, A. (2017) · Cancers · doi:10.3390/cancers9070085 · Cited by 59
“At present, the trigger for these immune reactions is unclear, and pre-clinical trials may have to be repeated [63].”
BackgroundInfluentialYu, W., Zhu, K., Wang, Y., Yu, H., & Guo, J. (2018) · Molecular Medicine · doi:10.1186/s10020-018-0034-5 · Cited by 56
“In addition, miR-21-5p was controlled by one gene called miR-21 and in previous studies, miR-21 has been proved to be capable of targeting many tumor suppressors such as PTEN (Meng et al., 2007), RECK (Gabriely et al., 2008), BTG2 (Liu et al., 2009) and TP63 (Papagiannakopoulos et al., 2008).”
Cannistraci, A., Pace, A. L. D., Maria, R. D., & Bonci, D. (2014) · BioMed Research International · doi:10.1155/2014/146170 · Cited by 57
“Notably, negative modulation of miR-205 in recurrent samples was confirmed also by Hulf et al. [55] who also demonstrated that this microRNA can impair cell viability of cancer cells through modulation of MED1 which has been correlated with castration-resistance acquisition [56].”
BackgroundRegulation of Metastasis by microRNAs in Ovarian Cancer
Wang, Y., Kim, S., & Kim, I. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00143 · Cited by 56
“For example, in glioma, miR-21 was suggested to be an oncomiR because of its ability to repress the expression of RECK and TIMP3 which are the inhibitors of matrix metalloproteinase (MMPs), thereby conferring the metastatic capabilities (34).”
BackgroundMicroRNAs in the cornea: Role and implications for treatment of corneal neovascularization
Mukwaya, A., Jensen, L. D., Peebo, B. B., & Lagali, N. (2019) · The Ocular Surface · doi:10.1016/j.jtos.2019.04.002 · Cited by 56
“In addition, Gabriely et al ., showed that miRNA-21 promotes tumour angiogenesis by suppressing the inhibitors of matrix metalloproteinases such as TIMP3 167 .”
Computational identification of specific genes for glioblastoma stem-like cells identity
Fiscon, G., Conte, F., Licursi, V., Nasi, S., & Paci, P. (2018) · Scientific Reports · doi:10.1038/s41598-018-26081-5 · Cited by 56
MicroRNAs as potential biomarkers in diseases and toxicology
Siddeek, B., Inoubli, L., Lakhdari, N., Paul, R., Fussell, K. C., Schneider, S., Mauduit, C., & Benahmed, M. (2014) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2014.01.010 · Cited by 55
Henriksen, M., Johnsen, K. B., Andersen, H. H., Pilgaard, L., & Duroux, M. C. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8668-y · Cited by 57
“, hMSH2), factors, which are all characteristics of GBM tumors [44, 48, 59, 70].”
BackgroundExtracellular Vesicles and MicroRNAs: Their Role in Tumorigenicity and Therapy for Brain Tumors
Bronisz, A., Godlewski, J. A., & Chiocca, E. A. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0293-4 · Cited by 57
“3).”
BackgroundGuo, W., Wu, Z., Yang, X., Pang, D., & Zhang, Z. (2019) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2019.02.026 · Cited by 55
A Local Proinflammatory Signalling Loop Facilitates Adverse Age-Associated Arterial Remodeling
Wang, M., Spinetti, G., Monticone, R. E., Zhang, J., Wu, J. T., Jiang, L., Khazan, B., Telljohann, R. S., & Lakatta, E. G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016653 · Cited by 54
“, MiR-21, has emerged as a potential modulator of transcriptional coregulation of TGF-b1 and MMP-2 [15,16].”
BackgroundExpression and function of miR-27b in human glioma
Kang, C. (2011) · Oncology Reports · doi:10.3892/or.2011.1458 · Cited by 54
“In contrast, miR-21 is almost invariably overexpressed in glio blastoma and a number of other tumor types, resulting in enhanced cell motility, migration and decreased apoptosis (8-10).”
Ohno, M., Natsume, A., Kondo, Y., Iwamizu, H., Motomura, K., Toda, H., Ito, M., Kato, T., & Wakabayashi, T. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0319 · Cited by 55
“miR-21 Overexpression in Glioma Cells, Particularly in the GICs Previously, miR-21 was suggested to be aberrantly expressed and to be one of the major antiapoptotic factors in malignant gliomas (16, 18, 20-22).”
BackgroundSagi, I., Talmi-Frank, D., Arkadash, V., Papo, N., & Mohan, V. (2016) · Metalloproteinases In Medicine · doi:10.2147/mnm.s65143 · Cited by 54
“Antisense inhibition of miR-21 has been considered a potential and novel anticancer therapy.(170) Intravenously administered chlorotoxin-coupled (targeted) stable-nucleic-acid-lipid-particle-formulated antimiR-21 oligonucleotides have been shown to promote efficient miR-21 silencing, preferentially in GBM.”
Lerner, N., Schreiber‐Avissar, S., & Beit‐Yannai, E. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15129 · Cited by 53
Serial selection for invasiveness increases expression of miR-143/miR-145 in glioblastoma cell lines
Koo, S., Martin, G. S., Schulz, K. J., Ronck, M., & Toussaint, L. G. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-143 · Cited by 54
“In recent years, a handful of microRNA species have been linked specifically to glioblastoma brain invasion [5-7].”
BackgroundMicroRNA-365 regulates NKX2-1, a key mediator of lung cancer
Kang, S., Lee, H., & Cho, J. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.03.006 · Cited by 53
“It targets genes including PDCD4, RECK, TIMPs, TPM1, SPRY2 and Maspin [15,16,28,31,59,60].”
BackgroundMicroRNA-34b functions as a tumor suppressor and acts as a nodal point in the feedback loop with Met
Wang, L., Yang, N., Su, B., Mu, X., Shen, H., & Du, J. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1767 · Cited by 55
Noncoding RNAs in breast cancer
Lo, P., Wolfson, B., Zhou, X., Duru, N., Gernapudi, R., & Zhou, Q. Y. (2015) · Briefings in Functional Genomics · doi:10.1093/bfgp/elv055 · Cited by 54
“Their gene targets encompass eight tumor suppressors (ATM, PTEN, FOXO1, FOXO3a, CYLD, BRCA1, EGR1 and WIF1) [56–58, 63, 64, 69, 72, 75], three pro-apoptotic factors (programmed cell death 4, PDCD4, SHC1 and BAX) [58, 59, 74], two inhibitors of matrix metalloproteinases (TIMP3 and RECK) implicated in regulating ECM deg…”
BackgroundWang, Y., Wang, S., Wu, Y., Ren, Y., Li, Z., Yao, X., Zhang, C., Ye, N., Jing, C., Dong, J., et al. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0606 · Cited by 53
Cortez, M. A., Ivan, C., Zhou, P., Wu, X., Ivan, M., & Calin, G. A. (2010) · Advances in cancer research · doi:10.1016/b978-0-12-380888-2.00004-2 · Cited by 53
Gu, N., Wang, X., Di, Z., et al. (2019) · Aging · doi:10.18632/aging.102455 · Cited by 53
“In recent years, microRNAs (miRNAs) have been found to be involved in the progression of all kinds of cancers and regarded as novel targets for anticancer therapies [12].”
BackgroundErdmann, E. A., Mahapatra, A., Mukherjee, P., Yang, B., & Hundley, H. A. (2020) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2020.1856768 · Cited by 52
“…instance, editing-dependent regulation of oncomiRNAs: miR-21, miR-221 and miR-222 are crucial determinants of glioblastoma progression. miR-21 promotes tumor cell migration whereas miR-221/−222 promotes cell proliferation through downregulation of p27 (Gabriely et al., 2008; Galardi et al., 2007).”
BackgroundOncogenic micro-RNAs and Renal Cell Carcinoma
Grange, C., Collino, F., Tapparo, M., & Camussi, G. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00049 · Cited by 51
“In addition, miR-21 has been correlated with the ability of glioma cells to migrate and invade, as a consequence of modulation of the metalloproteinase inhibitors, RECK and TIMP3 (27).”
miR-708 acts as a tumor suppressor in human glioblastoma cells
Pin, G., LAN, J., Ge, J., Nie, Q., Mao, Q., & Qiu, Y. (2013) · Oncology Reports · doi:10.3892/or.2013.2526 · Cited by 52
MicroRNAs as Regulators of Neural Stem Cell-Related Pathways in Glioblastoma Multiforme
González‐Gómez, P., Sánchez, P., & Mira, H. (2011) · Molecular Neurobiology · doi:10.1007/s12035-011-8196-y · Cited by 52
“hsa-miR-21 Anti-apoptotic [43], invasion [49], formation of colonies [109], drug sensitivity (see text) PTEN, RECK, MMPs inhibitors [49], PDCD4 [45], LRRFIP1 [55] [68] ; [69] ; [103] ; [62] ; [106] ; [56] ; [109] d A”
Regulation of Cell Proliferation and Migration in Glioblastoma: New Therapeutic Approach
Kim, Y. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00053 · Cited by 51
“For example, miR-21 promote glioma invasion by down-regulation of inhibitors of matrix metalloprotease (MMP) (Gabriely et al., 2008).”
BackgroundAlsibai, K. D., & Meseure, D. (2017) · Developmental Dynamics · doi:10.1002/dvdy.24548 · Cited by 53
“It seems that elevated levels of miR-21 down-regulate the tissue inhibitor of metalloproteinases-3 (TIMP-3) in gliomas and TIMP-2 in breast cancer, enhancing tumor local invasion and metastasis (Du et al., 2013; Gabriely et al., 2008).”
BackgroundEmerging Role of mTOR Signaling‐Related miRNAs in Cardiovascular Diseases
Samidurai, A., Kukreja, R. C., & Das, A. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/6141902 · Cited by 51
“Although miR-21 has been considered to promote cellular proliferation, invasion, and migration in various types of tumors [206, 207], rapamycin treatment induced the expression of miR-21 in human umbilical vein endothelial cells (HUVECs) but attenuated endothelial cell proliferation and migration [208].”
BackgroundDynamic Interplay between miRNAs and the Extracellular Matrix Influences the Tumor Microenvironment
Piperigkou, Z., & Karamanos, N. K. (2019) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2019.06.007 · Cited by 51
Kouri, F. M., Ritner, C., & Stegh, A. H. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1093711 · Cited by 52
microRNAs in the tumor microenvironment: solving the riddle for a better diagnostics
Challagundla, K. B., Fanini, F., Vannini, I., Wise, P. M., Murtadha, M., Malinconico, L., Cimmino, A., & Fabbri, M. (2014) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2014.922879 · Cited by 50
“miR-21 ECM PTEN, RECK, TIMP3 Up HCC, glioblastoma OG [86,87]”
BackgroundTargeting miR-21 in glioma: a small RNA with big potential
Moore, L. M., & Zhang, W. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2010.527334 · Cited by 51
“Bcl-2 Apoptosis Glioma Indirect [22,51] PTEN TSG/PI3K inhibition Glioma, hepatocellular cancer Direct [41,51]”
BackgroundInfluentialMicroRNAs dysregulation in epilepsy
Li, M., Li, X., Zheng, X., Yu, J., & Tan, L. (2013) · Brain Research · doi:10.1016/j.brainres.2013.09.049 · Cited by 51
“MiR-21 is an extensively studied miRNA as it is widely increased in multiple cancers (Gabriely et al., 2008; Kulshreshtha et al., 2007; van Rooij et al., 2006).”
BackgroundTumor microRNA-335 expression is associated with poor prognosis in human glioma
Jiang, J. W., Sun, X., Wang, W., et al. (2012) · Medical Oncology · doi:10.1007/s12032-012-0259-z · Cited by 51
“Its up-regulation contributes to various aspects of glioma tumorigenesis, including apoptosis, cell proliferation, invasiveness, and migration [18].”
BackgroundWang, X., Jiang, F., Mu, J., Ye, X., Si, L., Ning, S., Zhong, L., & Li, Y. (2014) · Toxicology Letters · doi:10.1016/j.toxlet.2014.03.016 · Cited by 51
MicroRNAs involved in the browning process of adipocytes
Arias, N., Aguirre, L., Fernández‐Quintela, A., González, M. A., Lasa, A., Miranda, J., Macarulla, M. T., & Portillo, M. P. (2015) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-015-0459-z · Cited by 51
MicroRNA-21 Increases Proliferation and Cisplatin Sensitivity of Osteosarcoma-Derived Cells
Vanas, V., Haigl, B., Stockhammer, V., & Sutterlüty, H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161023 · Cited by 51
“The metastatic process can also be influenced by miR-21 via regulation of substrates like Topomyosin [20], Reck und TIMP3 [21], factors which are known to modulate the extracellular matrix via metalloproteases.”
BackgroundResultPathogenic mechanisms of deregulated microRNA expression in thyroid carcinomas of follicular origin
Braun, J., & Hüttelmaier, S. (2011) · Thyroid Research · doi:10.1186/1756-6614-4-s1-s1 · Cited by 50
“By the direct targeting of RECK and the indirect effect on TIMP3 expression, upregulation of miR-21 promotes cell migration and invasiveness but also blocks apoptosis [67].”
BackgroundMicroRNAs in neural cell development and brain diseases
Feng, W., & Feng, Y. (2011) · Science China Life Sciences · doi:10.1007/s11427-011-4249-8 · Cited by 50
Genomics and epigenomics of colorectal cancer
Schweiger, M. R., Hussong, M., Röhr, C., & Lehrach, H. (2013) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1206 · Cited by 52
Li, M., Li, J., Liu, L., Li, W., Yang, Y., & Yuan, J. X. (2013) · Cancers · doi:10.3390/cancers5041306 · Cited by 51
Andrographolide Inhibits Angiogenesis by Inhibiting the Mir-21-5p/TIMP3 Signaling Pathway
Dai, J., Lin, Y., Duan, Y., Li, Z., Zhou, D., Chen, W., Wang, L., & Zhang, Q.-Q. (2017) · International Journal of Biological Sciences · doi:10.7150/ijbs.19194 · Cited by 50
“Therefore, miRNA-based drugs that target angiogenesis will likely be developed in the future. miR-21-5p is an important oncogenic miRNA that is often overexpressed in various solid tumors and its regulatory mechanism is well characterized. miR-21-5p could promote tumor growth and metastasis by targeting several tumor…”
BackgroundRole of phytochemicals in the modulation of miRNA expression in cancer
Debnath, T., Nath, N. C. D., Kim, E., & Lee, K. (2017) · Food & Function · doi:10.1039/c7fo00739f · Cited by 53
Wang, Z., Han, J., Cui, Y., Zhou, X., & Fan, K. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.08.072 · Cited by 49
Zhou, S., Zhang, S., Wang, Y., Yi, S., Zhao, L., Tang, X., Yu, B., Gu, X., & Ding, F. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.12.006 · Cited by 49
Johnston, S. T., Baker, R. E., McElwain, D. L. S., & Simpson, M. J. (2017) · Scientific Reports · doi:10.1038/srep42134 · Cited by 49
“The individual-level parameters are treated as being interchangeable with the continuum-level parameters as defined in (3).”
miR-21 Inhibitors Modulate Biological Functions of Gastric Cancer Cells via PTEN/PI3K/mTOR Pathway
Wang, P., Guan, Q., Zhou, D., Yu, Z., Song, Y., & Qiu, W. (2017) · DNA and Cell Biology · doi:10.1089/dna.2017.3922 · Cited by 49
“…in homolog deleted on chromosome ten (PTEN) (Meng et al. , 2007), programmed cell death 4 protein (PDCD4) (Asangani et al. , 2008), reversion-inducing-cysteine-rich protein with kazal motifs (RECK) (Gabriely et al. , 2008), RECK, and B cell lymphoma 2 (Bcl-2) (Papagiannakopoulos et al. , 2008).”
Noncoding RNAs in Glioblastoma: Emerging Biological Concepts and Potential Therapeutic Implications
Shahzad, U., Krumholtz, S. L., Rutka, J. T., & Das, S. (2021) · Cancers · doi:10.3390/cancers13071555 · Cited by 50
microRNA regulation of cell viability and drug sensitivity in lung cancer
Du, L., & Pertsemlidis, A. (2012) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2012.697149 · Cited by 49
“They further showed that TRAIL-sensitive H460 cells become resistant to TRAIL when treated with mimics of miR-221 and miR-222, while transfection with anti-miR-221 and anti-miR-222 render TRAIL-resistant Calu-1 cells sensitive, and that these effects are mediated by down-regulation of p27Kip1 (CDKN1B), PTEN and TIMP3…”
BackgroundInfluentialThe emerging role of tumor-suppressive microRNA-218 in targeting glioblastoma stemness
Gao, X., & Jin, W. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.07.011 · Cited by 49
“miR-21 is significantly elevated in GBM [24], and its inhibition sensitizes human glioblastoma U251 stem cells to chemotherapeutic drug [25].”
BackgroundRegulatory roles of microRNA-21 in fibrosis through interaction with diverse pathways (Review)
Liu, R., Ning, B., MA, X.-E., Gong, W.-M., & Jia, T. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.4834 · Cited by 51
“In addition, aberrantly expressed miR‑21 has been found to promote fibrogenic activation of fibroblasts (33,34). miR‑21 is able to regulate protein expression in multiple organs and tissues and has an impact on tumor development, cancer, inflammation and the immune system (30,35-38).”
Bao, S., Zheng, J., Li, N., Huang, C., Chen, M., Cheng, Q., Yu, K., Chen, S., Zhu, M., & Shi, G. (2017) · Gut and Liver · doi:10.5009/gnl16560 · Cited by 50
Krichevsky, A. M., & Uhlmann, E. J. (2019) · Neurotherapeutics · doi:10.1007/s13311-018-00702-3 · Cited by 48
Self-citationLi, K. K., Yang, L., Pang, J. C., Chan, A. K., Zhou, L., Mao, Y. Q., Wang, Y., Lau, K., Poon, W. S., Shi, Z., et al. (2012) · Brain Pathology · doi:10.1111/bpa.12015 · Cited by 49
“It has been shown to be downregulated in high-grade astrocytic tumors in two expression profiling studies but there is little information available concerning its functional role or its significance, especially in oligodendroglial tumors (14, 36).”
BackgroundRoles of microRNA‐34a in the pathogenesis of placenta accreta
Umemura, K., Ishioka, S., Endo, T., Ezaka, Y., Takahashi, M., & Saito, T. (2012) · Journal of obstetrics and gynaecology research · doi:10.1111/j.1447-0756.2012.01898.x · Cited by 47
“reported that inhibition of miR-21 in glioma cells induced downregulation of MMP activities.(24) Sun et al.”
BackgroundEsteso, G., Luzón, E., Sarmiento, E., Gómez-Caro, R., Steinle, A., Murphy, G., Carbone, J., Valés‐Gómez, M., & Reyburn, H. T. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303441 · Cited by 51
MicroRNA‐21 mediates the rapamycin‐induced suppression of endothelial proliferation and migration
Jin, C., Zhao, Y., Yu, L., Xu, S., & Fu, G. (2013) · FEBS Letters · doi:10.1016/j.febslet.2012.12.021 · Cited by 46
Differential response of miRNA-21 and its targets after traumatic brain injury in aging mice
Sandhir, R., Gregory, E. J., & Berman, N. E. J. (2014) · Neurochemistry International · doi:10.1016/j.neuint.2014.09.009 · Cited by 46
“…that miR-21 dysregulation contributes to increased gliosis and altered inflammatory responses in the aging brain (Onyszchuk et al., 2008; Sandhir et al., 2008; Bi et al., 2009). miR-21 also controls expression of RECK and TIMP3, key regulators of matrix metalloproteinases (Gabriely et al., 2008).”
BackgroundInfluentialRECK‐mediated inhibition of glioma migration and invasion
Corrêa, T. C. S., Massaro, R. R., Brohem, C. A., Taboga, S. R., Lamers, M. L., dos Santos, M. F., & Maria–Engler, S. S. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22472 · Cited by 46
“In glioma progression, from less invasive grade II gliomas to highly invasive GBMs, RECK mRNA level decreases [Gabriely et al., 2008].”
BackgroundMicroRNA in cancer: New hopes for antineoplastic chemotherapy
Leva, G. D., Briskin, D., & Croce, C. M. (2012) · Upsala Journal of Medical Sciences · doi:10.3109/03009734.2012.660551 · Cited by 47
“Another microRNAwith oncogenic activity is represented by miR-21, which is highly expressed in the majority of human malignancies thus far analyzed, including breast cancer (46,47), glioblastoma (48,49), hepatocellular carcinoma (50), cholangiocarcinoma (51), lungcancer (52), tongue squamouscell carcinoma (53), esopha…”
BackgroundHexokinase 2 (HK2), the tumor promoter in glioma, is downregulated by miR-218/Bmi1 pathway
Liu, H., Liu, N., Cheng, Y., Jin, W., Zhang, P., Wang, X., Yang, H., Xu, X., Wang, Z., & Tu, Y. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189353 · Cited by 46
Long noncoding RNAs: a new regulatory code in osteoarthritis.
Cen, X. B., Huang, X., Sun, W., Liu, Q., & Liu, J. (2017) · Europe PMC (PubMed Central) · Cited by 46
Wang, S., Ma, F., Feng, Y., Liu, T., & He, S. (2020) · International Journal of Oncology · doi:10.3892/ijo.2020.4992 · Cited by 48
“Functional analyses in epithelial-, hepatocyte- and glial cell-derived cell lines support the regulatory role of miR-21 in cell growth, migration and invasion (46,47,55-57).”
Background
Metadata
- Authors
- Gabriely, G., Wurdinger, T., Kesari, S., Esau, C. C., Burchard, J., Linsley, P. S., & Krichevsky, A. M.
- Affiliations
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Regulus Therapeutics (United States) (US)
- Corresponding author
- Krichevsky, Anna M.
- ORCID
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2008-09-01
- Volume
- 28
- Issue
- 17
- Pages
- 5369-5380
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC2519720
- OpenAlex
- W2163655902
- Cited by
- 888
- References
- 62
- Citations by year
- 2026: 13 · 2025: 19 · 2024: 21 · 2023: 29 · 2022: 20 · 2021: 21 · 2020: 43 · 2019: 41 · 2018: 33 · 2017: 56 · 2016: 56 · 2015: 75 · 2014: 76 · 2013: 86 · 2012: 91
- FWCI
- 21.02
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Molecular and Cellular Biology (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- PubMed Central (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- National Institutes of Health (CA86355)
- National Cancer Institute (R21 CA116141, P50 CA86355-04, P50CA086355)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Keywords
- miR-21, glioma invasion, glioblastoma, matrix metalloproteinases, RECK, TIMP-3, matrix metalloproteinase inhibitors, cell migration, apoptosis, antisense oligonucleotides, microRNA inhibition, tumor malignancy
- MeSH terms
- Animals, Base Sequence, Cell Movement, Enzyme Inhibitors, Extracellular Matrix, Glioma, Humans, Molecular Sequence Data, Neoplasm Invasiveness, Neoplasm Transplantation, RNA, Messenger, Down-Regulation, Gene Expression Regulation, Neoplastic, Apoptosis, Disease Progression, Oligonucleotide Array Sequence Analysis, Matrix Metalloproteinases, Gene Expression Profiling, MicroRNAs, Cell Line, Tumor, Mice, Genes, Neoplasm, Matrix Metalloproteinase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-19, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-19 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review